Clinical efficacy of levocarnitine supplementation in patients with hemodialysis
Not Applicable
- Conditions
- Hemodialysis patients
- Registration Number
- JPRN-UMIN000015185
- Lead Sponsor
- Keiai Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
(1) history of amputation of extremities or the presence of peripheral arterial disease; (2) a history of severe heart failure, angina, myocardial infarction, or stroke within the past 6 months; (3) the presence of infectious disease, thyroid disease, malignant tumors, or treatment with steroids or immunosuppressants; and (4) L-carnitine supplementation within the past 6 months.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method cardiac function, renal anemia, atherosclerosis
- Secondary Outcome Measures
Name Time Method